FoundationOne Liquid CDx (F1LCDx)
FDA premarket approval P190032/S026 · decided 2024-11-02
Approval details
- PMA number
- P190032
- Supplement
- S026
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- FoundationOne Liquid CDx (F1LCDx)
- Generic name
- Next generation sequencing oncology panel, somatic or germline variant detection system
- Applicant
- Foundation Medicine, Inc.
- Date received
- 2024-10-02
- Decision date
- 2024-11-02
- Days to decision
- 31 days
- Decision code
- OK30
- Product code
- PQP
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- Boston, MA
- Statement
- outsourcing of a manufacturing process to an approved and qualified supplier
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.